Matches in Nanopublications for { ?s ?p "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP773608.RAnWdjQR6xM32gx6iFMTMXlowVowaT7mnLmJoDCP574_s130_assertion description "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773608.RAnWdjQR6xM32gx6iFMTMXlowVowaT7mnLmJoDCP574_s130_provenance.
- NP440672.RASGhj-PbUr_GBsoOFhGAFrJYxwSwIlLQ554NcKpyY790130_assertion description "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440672.RASGhj-PbUr_GBsoOFhGAFrJYxwSwIlLQ554NcKpyY790130_provenance.
- NP748897.RAV3pbvn3rVoxmeYewTPcTYPGBiZ5TsbpHimKbS5k80vo130_assertion description "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748897.RAV3pbvn3rVoxmeYewTPcTYPGBiZ5TsbpHimKbS5k80vo130_provenance.
- assertion description "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP762137.RAkuQo-aGYwEHav1oKBekZdqNq9UqmnKpKzJeyHABmzWo130_assertion description "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762137.RAkuQo-aGYwEHav1oKBekZdqNq9UqmnKpKzJeyHABmzWo130_provenance.
- NP748862.RAGCA3iJQ2gsj5MKfOr-kQ6pPUMW-rYArHkvot8epdwkY130_assertion description "[Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748862.RAGCA3iJQ2gsj5MKfOr-kQ6pPUMW-rYArHkvot8epdwkY130_provenance.